⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
SAMMAANCAP - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.1
| Stock Code | SAMMAANCAP | Market Cap | 11,703 Cr. | Current Price | 141 ₹ | High / Low | 193 ₹ |
| Stock P/E | 10.2 | Book Value | 281 ₹ | Dividend Yield | 0.00 % | ROCE | 9.12 % |
| ROE | 4.63 % | Face Value | 2.00 ₹ | DMA 50 | 146 ₹ | DMA 200 | 146 ₹ |
| Chg in FII Hold | 5.89 % | Chg in DII Hold | -2.52 % | PAT Qtr | 285 Cr. | PAT Prev Qtr | 275 Cr. |
| RSI | 44.0 | MACD | -2.03 | Volume | 51,84,118 | Avg Vol 1Wk | 57,61,424 |
| Low price | 97.6 ₹ | High price | 193 ₹ | PEG Ratio | 0.94 | Debt to equity | 1.85 |
| 52w Index | 45.6 % | Qtr Profit Var | 1.01 % | EPS | 13.9 ₹ | Industry PE | 14.1 |
📊 Financial Overview
- Revenue & Profit Growth: Quarterly PAT rose slightly from ₹275 Cr. to ₹285 Cr. (1.01% growth).
- Margins: ROE at 4.63% and ROCE at 9.12% → weak efficiency.
- Debt: Debt-to-equity ratio of 1.85 → high leverage.
- Cash Flow: Stable but constrained by debt servicing.
- Return Metrics: EPS at ₹13.9, modest earnings power.
💹 Valuation Indicators
- P/E Ratio: 10.2 vs Industry PE of 14.1 → undervalued.
- P/B Ratio: Price ₹141 / Book Value ₹281 ≈ 0.50 → trading below book value.
- PEG Ratio: 0.94 → fairly valued relative to growth.
- Intrinsic Value: Appears undervalued, offering margin of safety.
🏢 Business Model & Competitive Advantage
- Operates in financial services and capital markets.
- Competitive advantage lies in institutional participation and sector exposure.
- High debt and weak return ratios limit overall health.
- Strong FII interest provides confidence in long-term prospects.
📈 Entry Zone Recommendation
- Technicals: RSI at 44.0 (neutral), MACD negative, price near 50DMA and 200DMA (146).
- Entry Zone: Attractive accumulation near ₹135–145 for long-term investors.
- Holding Guidance: Suitable for value investors; long-term holding requires improvement in ROE and debt reduction.
✅ Positive
- Stock trades below book value (P/B 0.50).
- Low P/E (10.2) compared to industry average (14.1).
- FII holdings increased (+5.89%).
⚠️ Limitation
- Weak ROE (4.63%) and ROCE (9.12%).
- High debt-to-equity ratio (1.85).
- No dividend yield (0.00%).
📉 Company Negative News
- DII holdings decreased (-2.52%).
- Stock corrected from ₹193 to ₹141.
- Technical indicators (MACD negative) show bearish sentiment.
📈 Company Positive News
- Quarterly PAT improved slightly to ₹285 Cr.
- FII confidence increased significantly (+5.89%).
- Stock trading below intrinsic value offers margin of safety.
🌐 Industry
- Financial services sector remains critical for capital market growth.
- Industry PE at 14.1 indicates sector trades at higher valuations compared to SAMMAANCAP.
- Institutional participation supports long-term sector stability.
🔎 Conclusion
- SAMMAANCAP appears undervalued with strong FII interest but suffers from weak profitability and high debt.
- Valuation offers margin of safety, but fundamentals need improvement.
- Best considered for value investors with entry near ₹135–145; long-term holding depends on debt reduction and ROE improvement.